Stability of ursodiol 25 mg/mL in an extemporaneously prepared oral liquid

被引:5
作者
Mallett, MS
Hagan, RL
Peters, DA
机构
[1] WARNER LAMBERT PARKE DAVIS,PARKE DAVIS PHARMACEUT RES,MORRIS PLAINS,NJ 07950
[2] DAVID GRANT MED CTR,DEPT PHARM,PHARM SUPPORT SERV,CLIN INVEST FACIL,TRAVIS AFB,CA
关键词
capsules; cholelitholytic agents; compounding; formulations; glycerin; incompatibilities; orange syrup; stability; storage; suspending agents; suspensions; sweetening agents; temperature; ursodiol; vehicles;
D O I
10.1093/ajhp/54.12.1401
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The stability of ursodiol in an extemporaneously formulated oral liquid was studied. A suspension was prepared by combining the contents of commercially available 300-mg capsules of ursodiol with glycerin, Ora-Plus (Paddock Laboratories), and orange syrup. A second formulation was prepared by combining ursodiol capsules with sterile water for irrigation. The final concentration of ursodiol in each formulation was 25 mg/mL. Six samples of each preparation were stored in 4-oz amber plastic prescription bottles protected from light. Three were stored at 22-23 degrees C and three were refrigerated al 2-6 degrees C. Immediately after preparation and at 7, 15, 30, 45, and 60 days, samples were obtained and frozen until assay by high-performance liquid chromatography. On day 60 the mean percentage of the initial ursodiol concentration remaining was 108.4% for the suspension stored at room temperature and 103.3% for the refrigerated suspension. The ursodiol-in-water formulation was not analyzed because of rapid settling of ursodiol. Ursodiol 25 mg/mL in an oral liquid prepared extemporaneously from capsules and sweetened vehicle was stable for 60 days when stored in amber plastic bottles at 22-23 and 2-6 degrees C. Addition of ursodiol powder to water without a suspending agent resulted in a liquid formulation with a high variability in content uniformity.
引用
收藏
页码:1401 / 1404
页数:4
相关论文
共 50 条
  • [41] STABILITY OF FLECAINIDE ACETATE IN AN EXTEMPORANEOUSLY COMPOUNDED ORAL SUSPENSION
    WIEST, DB
    GARNER, SS
    PAGACZ, LR
    ZEIGLER, V
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1992, 49 (06): : 1467 - 1470
  • [42] Stability of labetalol hydrochloride, metoprolol tartrate, verapamil hydrochloride, and spironolactone with hydrochlorothiazide in extemporaneously compounded oral liquids
    Allen, LV
    Erickson, MA
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (19) : 2304 - 2309
  • [43] Stability of acetazolamide, allopurinol, azathioprine, clonazepam, and flucytosine in extemporaneously compounded oral liquids
    Allen, LV
    Erickson, MA
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (16) : 1944 - 1949
  • [44] Formulation and stability evaluation of an extemporaneously prepared baclofen suspension (1 mg/mL)
    Purohit, Trusha J.
    Thakur, Sachin S.
    Carruth, Jonathan
    Dean, Farhan
    Kim, Darin
    Lee, Seunghyun
    Liu, Colin
    Sharma, Manisha
    Hanning, Sara M.
    [J]. JOURNAL OF PHARMACY PRACTICE AND RESEARCH, 2021, 51 (04) : 314 - 320
  • [45] Stability of zonisamide in extemporaneously compounded oral suspensions
    Abobo, Cyril V.
    Wei, Bo
    Liang, Dong
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (12) : 1105 - 1109
  • [46] Stability of extemporaneously prepared clofazimine oral suspensions
    Ponsonby-Thomas, Ellie
    Lau, Charis
    Tan, Sherine
    Salim, Malinda
    Boyd, Ben J.
    [J]. JOURNAL OF PHARMACY PRACTICE AND RESEARCH, 2024, 54 (01) : 55 - 60
  • [47] Stability of baclofen, captopril, diltiazem hydrochloride, dipyridamole, and flecainide acetate in extemporaneously compounded oral liquids
    Allen, LV
    Erickson, MA
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (18) : 2179 - 2184
  • [48] Stability of alprazolam, chloroquine phosphate, cisapride, enalapril maleate, and hydralazine hydrochloride in extemporaneously compounded oral liquids
    Allen, LV
    Erickson, MA
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 (18) : 1915 - 1920
  • [49] Stability of amphotericin B in an extemporaneously prepared iv fat emulsion
    Lopez, RM
    Ayestaran, A
    Pou, L
    Montoro, JB
    Hernandez, M
    Caragol, I
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (22) : 2724 - 2727
  • [50] Stability of an extemporaneously prepared alcohol-free phenobarbital suspension
    Cober, Mary Petrea
    Johnson, Cary E.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (06) : 644 - 646